<DOC>
	<DOCNO>NCT01199861</DOCNO>
	<brief_summary>This study evaluate effect treatment fingolimod immune response follow seasonal influenza vaccination tetanus booster injection patient relapse MS .</brief_summary>
	<brief_title>Effect Treatment With Fingolimod Immune Response Following Seasonal Flu Vaccination Tetanus Booster Injection Patients With Relapsing Multiple Sclerosis ( MS )</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Must relapse MS Must lifetime tetanus vaccination Agree receive 2010/2011 seasonal influenza vaccine tetanus toxoid booster injection Patients type MS relapse Patients history chronic immune disease Certain cancer Diabetic patient certain eye disorder Patients certain immunosuppressive medication heart medication Patients certain heart condition Patients certain lung condition Patients already receive 2010/2011 seasonal influenza vaccine Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Relapsing multiple sclerosis</keyword>
	<keyword>MS</keyword>
	<keyword>Immune response</keyword>
</DOC>